Join
Live feed
·
INSIDERFilingvia Quantisnow
Terns Pharmaceuticals Inc. logo

Chief Financial Officer Gengos Andrew was granted 68,750 shares, increasing direct ownership by 208% to 101,788 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TERN· Terns Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TERN (Terns Pharmaceuticals Inc.) and more on Quantisnow.